A Study To Establish The Equivalence Of 2 Palbociclib (PD-0332991) Formulations To The Intended Final Market Product
Clinical trial NCT01906125 · COMPLETED
Trial details
- NCT number
- NCT01906125
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-01
- Primary completion
- 2014-01-01
- Enrollment
- 73
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.